83-98-7 (邻甲苯海拉明,Ethanamine,N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-)

邻甲苯海拉明;奥芬;奥芬-D3;奥芬-D3盐酸;奥芬-D4;邻甲苯海明;2-(苯基邻甲苯甲氧基)乙基二甲基胺;奥芬那君;

Ethanamine,N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-;N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;Orphenadrine;ORPHENADRINE RELATED COMPOUND A (RS)-N,N-DIMETHYL-2-[(3-METHYLPHENYL)-PHENYLMETHOXY]ETHANAMINE CITRATE (AS) ,USP STANDA...;<2-Dimethylamino-aethyl>-<2-methyl-benzhydryl>-aether;2-Methyldiphenhydramine;Biorphen;Brocadisipal;Dimethyl-[2-(2-methyl-benzhydryloxy)-aethyl]-amin;dimethyl-[2-(2-methyl-benzhydryloxy)-ethyl]-amine;Disipal;Mephenamine;o-Methyldiphenhydramine;Orphenadine;Orphenadrin;Orphenedrine;Mialgin;EINECS 201-509-2;BSPBio_002141;ORPHENADRINE [MI];NCGC00015771-10;ORPHENADRINE [HSDB];NCGC00015771-05;AL805O9OG9;2-(Phenyl-o-tolylmethoxy)ethyldimethylamine;N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine #;AB00053510;N,N-dimethyl-2-((2-methylphenyl)(phenyl)methoxy)ethanamine;Dimethyl-(2-(phenyl-o-tolyl-methoxy)-ethyl)-amine;Spectrum4_000460;BDBM50062614;ORPHENADRINE [VANDF];(+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE;KBio2_001525;N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine;Prestwick3_000239;Norgesic;KBioSS_001525;Invagesic;(+/-)-N,N-DIMETHYL-2-((O-METHYL-alpha-PHENYLBENZYL)OXY)ETHYLAMINE;N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine;Q3292273;dimethyl-2[alpha-(o-tolyl)benzyloxy]ethylamine;Lopac0_000884;SDCCGSBI-0050859.P005;Orphenadinum;KBio2_006661;CBDivE_006102;AB00053510_20;KBio2_004093;ORPHENADRINE [WHO-DD];UNII-AL805O9OG9;Methyldiphenylhydramine;NCGC00089814-05;BRD-A53576514-048-06-9;4-06-00-04727 (Beilstein Handbook Reference);CHEBI:7789;beta-Dimethylaminoethyl 2-methylbenzhydryl ether;N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyl)oxy)ethylamine;ORPHENADRINE [INN];SBI-0050859.P004;KBio3_001641;Orphenadrinum (INN-Latin);NCGC00015771-12;AB00053510_21;Prestwick2_000239;Prestwick0_000239;Orfenadrina;NCGC00015771-03;Orphenadrine [INN:BAN];SPBio_002238;DB01173;Ethylamine, N,N-dimethyl-2-((o-methyl-.alpha.-phenylbenzyl)oxy)-;QVYRGXJJSLMXQH-UHFFFAOYSA-N;N,N-Dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine;GTPL7251;Spectrum_001045;N,N-dimethyl-2-{[(2-methylphenyl)(phenyl)methyl]oxy}ethanamine;Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-;MEFENAMINE [JAN];N,N-Dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine;KBio1_000853;Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-;Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine;BRN 1885151;CCG-204966;NS00009478;A899996;KBioGR_000880;Orphengesic;o-Monomethyldiphenhydramine;IDI1_000853;NCGC00089814-03;BSPBio_000317;ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-;EN300-708773;Spectrum3_000531;Brocasipal (Salt/Mix);D08305;83-98-7;CHEMBL900;.beta.-Dimethylaminoethyl 2-methylbenzhydryl ether;Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-;Mephenamine (Salt/Mix);N04AB02;NCGC00015771-07;NCGC00089814-02;Oprea1_476547;N,N-Dimethyl-2-[(o-methyl-.alpha.-phenylbenzyl)oxy]ethylamine;Prestwick1_000239;Orfenadrina [INN-Spanish];BRD-A53576514-003-03-1;DivK1c_000853;NCGC00015771-06;Orfenadrina (INN-Spanish);Mefenamine;Orphenadrinum [INN-Latin];beta-Dimethylaminoethyl-2-methylbenzhydryl ether;BPBio1_000349;L001253;Phenyl-o-tolylmethyl dimethyaminoethyl ether;Orphenadrine (INN);NINDS_000853;N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamin;C07935;SPBio_001255;Orphenate;ORP;DTXSID3023396;NCGC00015771-09;Orphenadrinum;Mialgin (TN);HSDB 3139;DTXCID003396;BS-5930;dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine;WS 2434;NCGC00015771-22;Spectrum2_001038;AB00053510-19;SCHEMBL28727;N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine;M03BC01;Spectrum5_001036;Phenyl-o-tolylmethyl dimethylaminoethyl ether;CS-1010546;BRD-A53576514-048-14-3;HY-157959;BRD-A53576514-048-13-5;

MFCD00053670

QVYRGXJJSLMXQH-UHFFFAOYSA-N

1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3

O(CCN(C)C)C(C1C=CC=CC=1)C1C=CC=CC=1C

2922199090